Suppression of the antigen-stimulated RBL-2H3 mast cell activation by artekeiskeanol A

Planta Medica

Volumn 75, Issue 14, 2009, Pages 1494-1498

  Hong, Jangja ^a   Sasaki, Hirokazu ^b   Hirasawa, Noriyasu ^b   Ishihara, Kenji ^b   Kwak, Jong Hwan ^c   Zee, Okpyo ^c   Schmitz, Francis J ^d   Seyama, Toshio ^a   Ohuchi, Kazuo ^a  

^a YASUDA WOMEN'S UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Sungkyunkwan University   (South Korea)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Artekeiskeanol A; Artemisia keiskeana Miq.; Compositae; Degranulation; IL 13; RBL 2H3 cells; TNF

Indexed keywords

2,4 DINITROPHENOL; ANTIGEN; ARTEKEISKEANOL A; CALCIMYCIN; COUMARIN DERIVATIVE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; THAPSIGARGIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTEMISIA; ARTICLE; CELL ACTIVATION; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; IC 50; IMMUNOMODULATION; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIGENS; ARTEMISIA; CALCIMYCIN; CELL DEGRANULATION; CELL LINE, TUMOR; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; INHIBITORY CONCENTRATION 50; INTERLEUKIN-13; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; RATS; RNA, MESSENGER; SERUM ALBUMIN; TERPENES; THAPSIGARGIN; TUMOR NECROSIS FACTOR-ALPHA;

ARTEMISIA KEISKEANA; ASTERACEAE;

EID: 73349110908     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185798     Document Type: Article

References (22)

1. Shanghai Scientific and Technologic Publisher and Shougakukan. The dictionary of Chinese drugs, Vol.1. Tokyo Shougakukan 1985 19
2. Kwak J H., Lee K B., Schmitz F J. Four new coumarin derivatives from Artemisia keiskeana. J Nat Prod Med 2001 64 1081-1083
3. Williams C M., Galli S J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000 105 847-859
4. 2 pathway in a rat mast cell line. Indication of different pathways for release of arachidonic acid and secretory granules. J Immunol 1995 154 5395-5401
5. Hirasawa N, Sato Y, Fujita Y, Ohuchi K. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL4 production in mast cells. Biochim Biophys Acta 2000 1456 45-55
6. Hirasawa N, Izumi S, Linwong W, Ohuchi K. Inhibition by dexamethasone of interleukin 13 production via glucocorticoid receptor-mediated inhibition of c-Jun phosphorylation. FEBS Lett 2003 554 489-493
7. Bridges A J., Malone D G., Jicinsky J, Chen M, Ory P, Engber W, Graziano F M. Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum 1991 34 1116-1124
8. Kobayashi Y, Okunishi H. Mast cells as a target of rheumatoid arthritis treatment. Jpn J Pharmacol 2002 90 7-11
9. Lee D M., Friend D S., Gurish M F., Benoist C, Mathis D, Brenner M B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002 297 1689-1692
10. Eklund K K. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007 217 38-52
11. Hirasawa N, Sato Y, Fujita Y, Mue S, Ohuchi K. Inhibition by dexamethasone of mitogen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. J Immunol 1998 161 4939-4943
12. Huber M, Hughes M R., Krystal G. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase. J Immunol 2000 165 124-133
13. Zhang G, Baumgartner R A., Yamada K, Beaven M A. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor- and release of arachidonic acid in mast cells. Indications of communication between p38 and p42 MAP kinases. J Biol Chem 1997 272 13397-13402
14. Beutler B, Cerami A. The biology of cachectin/TNF-α-a primary mediator of the host response. Annu Rev Immunol 1989 7 625-655
15. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben T Y., Karp C L., Donaldson D D. Interleukin-13: central mediator of allergic asthma. Science 1998 282 2258-2261
16. Gon Y, Nunomura S, Ra C. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL2H3 cells. Clin Exp Allergy 2005 35 635-642
17. Ryu S Y., Kou N Y., Choi H S., Ryu H, Kim T S., Kim K M. Cnidicin, a coumarin, from the root of Angelica koreana, inhibits the degranulation of mast cell and the NO generation in RAW 264.7 cells. Planta Med 2001 67 172-174
18. Kishiro S, Nunomura S, Nagai H, Akihisa T, Ra C. Selinidin suppresses IgE-mediated mast cell activation by inhibiting multiple steps of FcRI signaling. Biol Pharm Bull 2008 31 442-448
19. Watanabe J, Shinmoto H, Tsushida T. Coumarin and flavone derivatives from estragon and thyme as inhibitors of chemical mediator release from RBL2H3 cells. Biosci Biotechnol Biochem 2005 69 1-6
20. Moon P D., Lee B H., Jeong H J., An H J., Park S J., Kim H R., Ko S G., Um J Y., Hong S H., Kim H M. Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IkappaB/NF-kappaB signal cascade in the human mast cell line HMC1. Eur J Pharmacol 2007 555 218-225
21. Martin U, Roemer D. Ketotifen: a histamine release inhibitor. Monogr Allergy 1977 12 145-149
22. Fischer B, Schmutzler W. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells. Arzneimittelforschung 1981 31 1193-1195